These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 14688140

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans.
    Zaric M, Marini A, Nielsen CM, Gupta G, Mekhaiel D, Pham TP, Elias SC, Taylor IJ, de Graaf H, Payne RO, Li Y, Silk SE, Williams C, Hill AVS, Long CA, Miura K, Biswas S.
    Front Immunol; 2021; 12():732667. PubMed ID: 34659219
    [Abstract] [Full Text] [Related]

  • 23. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
    Jones RM, Chichester JA, Manceva S, Gibbs SK, Musiychuk K, Shamloul M, Norikane J, Streatfield SJ, van de Vegte-Bolmer M, Roeffen W, Sauerwein RW, Yusibov V.
    Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525
    [Abstract] [Full Text] [Related]

  • 24. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.
    LeBlanc R, Vasquez Y, Hannaman D, Kumar N.
    Vaccine; 2008 Jan 10; 26(2):185-92. PubMed ID: 18054817
    [Abstract] [Full Text] [Related]

  • 25. Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
    Radtke AJ, Anderson CF, Riteau N, Rausch K, Scaria P, Kelnhofer ER, Howard RF, Sher A, Germain RN, Duffy P.
    Sci Rep; 2017 Jan 16; 7():40312. PubMed ID: 28091576
    [Abstract] [Full Text] [Related]

  • 26. Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles.
    Kumar R, Ledet G, Graves R, Datta D, Robinson S, Bansal GP, Mandal T, Kumar N.
    Pharm Res; 2015 Dec 16; 32(12):3827-36. PubMed ID: 26113235
    [Abstract] [Full Text] [Related]

  • 27. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
    Near KA, Stowers AW, Jankovic D, Kaslow DC.
    Infect Immun; 2002 Feb 16; 70(2):692-701. PubMed ID: 11796601
    [Abstract] [Full Text] [Related]

  • 28. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.
    Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB.
    Infect Immun; 1994 Dec 16; 62(12):5576-80. PubMed ID: 7960139
    [Abstract] [Full Text] [Related]

  • 29. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
    Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, Lee CK, Ockenhouse CF, Morin MJ, Streatfield SJ, Yusibov V.
    Vaccine; 2018 Sep 18; 36(39):5865-5871. PubMed ID: 30126674
    [Abstract] [Full Text] [Related]

  • 30. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.
    Infect Immun; 2013 Dec 18; 81(12):4377-82. PubMed ID: 24042109
    [Abstract] [Full Text] [Related]

  • 31. Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice.
    Nazeri S, Zakeri S, Mehrizi AA, Djadid ND, Snounou G, Andolina C, Nosten F.
    Med Microbiol Immunol; 2018 Nov 18; 207(5-6):271-286. PubMed ID: 29948091
    [Abstract] [Full Text] [Related]

  • 32. Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.
    Scally SW, McLeod B, Bosch A, Miura K, Liang Q, Carroll S, Reponen S, Nguyen N, Giladi E, Rämisch S, Yusibov V, Bradley A, Lemiale F, Schief WR, Emerling D, Kellam P, King CR, Julien JP.
    Nat Commun; 2017 Nov 16; 8(1):1568. PubMed ID: 29146922
    [Abstract] [Full Text] [Related]

  • 33. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.
    Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE.
    Vaccine; 2007 May 16; 25(20):3923-33. PubMed ID: 17428587
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV, Biswas S, Pillai CR, Saxena RK.
    Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786
    [Abstract] [Full Text] [Related]

  • 35. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen.
    Mlambo G, Kumar N, Yoshida S.
    Vaccine; 2010 Oct 08; 28(43):7025-9. PubMed ID: 20709008
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 37. A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies.
    Stowers AW, Keister DB, Muratova O, Kaslow DC.
    Infect Immun; 2000 Oct 15; 68(10):5530-8. PubMed ID: 10992450
    [Abstract] [Full Text] [Related]

  • 38. Cd loop fusion enhances the immunogenicity and the potential transmission blocking activity of Plasmodium falciparum generative cell specific 1 (GCS1) antigen.
    Nourani L, Ayoub Meigouni M, Afzali S, Zargar M, Pourhashem Z, Yousefi H, Sani JJ, Vand-Rajabpour H, Pirahmadi S, Raz A, Abouie Mehrizi A.
    Biochem Biophys Res Commun; 2024 Nov 12; 733():150599. PubMed ID: 39208643
    [Abstract] [Full Text] [Related]

  • 39. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
    Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC.
    J Exp Med; 1991 Nov 01; 174(5):1203-8. PubMed ID: 1940798
    [Abstract] [Full Text] [Related]

  • 40. Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
    An SJ, Scaria PV, Chen B, Barnafo E, Muratova O, Anderson C, Lambert L, Chae MH, Yang JS, Duffy PE.
    Vaccine; 2018 May 17; 36(21):2978-2984. PubMed ID: 29681410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.